Annual Non Current Assets
$25.03 M
-$3.77 M-13.10%
31 December 2023
Summary:
SAB Biotherapeutics annual long term assets is currently $25.03 million, with the most recent change of -$3.77 million (-13.10%) on 31 December 2023. During the last 3 years, it has risen by +$2.95 million (+13.37%). SABS annual non current assets is now -19.11% below its all-time high of $30.95 million, reached on 31 December 2021.SABS Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$21.26 M
-$1.05 M-4.71%
30 September 2024
Summary:
SAB Biotherapeutics quarterly long term assets is currently $21.26 million, with the most recent change of -$1.05 million (-4.71%) on 30 September 2024. Over the past year, it has dropped by -$3.95 million (-15.66%). SABS quarterly non current assets is now -81.70% below its all-time high of $116.16 million, reached on 30 September 2021.SABS Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.1% | -15.7% |
| 3 y3 years | +13.4% | -81.7% |
| 5 y5 years | - | - |
SABS Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -19.1% | +13.4% | -81.7% | at low |
| 5 y | 5 years | -19.1% | +187.3% | -81.7% | at low |
| alltime | all time | -19.1% | +187.3% | -81.7% | at low |
SAB Biotherapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $21.26 M(-4.7%) |
| June 2024 | - | $22.31 M(-8.6%) |
| Mar 2024 | - | $24.42 M(-2.5%) |
| Dec 2023 | $58.91 M(+166.6%) | $25.03 M(-0.7%) |
| Sept 2023 | - | $25.21 M(-4.6%) |
| June 2023 | - | $26.44 M(-4.4%) |
| Mar 2023 | - | $27.64 M(-4.1%) |
| Dec 2022 | $22.10 M | $28.81 M(-5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $30.33 M(-3.4%) |
| June 2022 | - | $31.40 M(+0.3%) |
| Mar 2022 | - | $31.30 M(+1.1%) |
| Dec 2021 | $50.19 M(+45.7%) | $30.95 M(-73.4%) |
| Sept 2021 | - | $116.16 M(+339.3%) |
| June 2021 | - | $26.44 M(+19.7%) |
| Dec 2020 | $34.45 M(+270.9%) | $22.08 M |
| Dec 2019 | $9.29 M | - |
FAQ
- What is SAB Biotherapeutics annual long term assets?
- What is the all time high annual non current assets for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual non current assets year-on-year change?
- What is SAB Biotherapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly non current assets year-on-year change?
What is SAB Biotherapeutics annual long term assets?
The current annual non current assets of SABS is $25.03 M
What is the all time high annual non current assets for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual long term assets is $30.95 M
What is SAB Biotherapeutics annual non current assets year-on-year change?
Over the past year, SABS annual long term assets has changed by -$3.77 M (-13.10%)
What is SAB Biotherapeutics quarterly long term assets?
The current quarterly non current assets of SABS is $21.26 M
What is the all time high quarterly non current assets for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly long term assets is $116.16 M
What is SAB Biotherapeutics quarterly non current assets year-on-year change?
Over the past year, SABS quarterly long term assets has changed by -$3.95 M (-15.66%)